A new machine learning model can predict how quickly diabetic retinopathy will progress in individual patients. Unexpectedly, the algorithm relies on information clinicians rarely consider in routine ...

Diabetic retinopathy is a complication of diabetes that affects vision. Nonproliferative diabetic retinopathy describes the earlier stages of the condition before it progresses into the final and most ...

CONDOR randomized 689 adults with type 1/2 diabetes and PRP-naïve PDR across 152 sites in 16 countries; 572 completed the week-54 visit. Brolucizumab was administered q6w for three doses then q12w, ...

Ultrawidefield and 7 field imaging determine diabetic retinopathy severity levels with good concordance. Researchers included 785 participants (mean age, 61 years; 47% women) with type 1 diabetes from ...

Longer-term follow-up of a randomized trial confirmed that prophylactic anti-VEGF therapy with aflibercept (Eylea) slows progression of diabetic retinopathy but does not improve visual acuity better ...

No changes in diabetic retinopathy status occurred in high-risk people with type 2 diabetes taking tirzepatide when compared with dulaglutide.

Microaneurysms are tiny areas of swelling in the blood vessels of your eye. They can be a clue to worsening diabetic retinopathy and may indicate that you need treatment to help prevent vision loss.

A four-year clinical study has found that while early treatment of diabetes-related eye disease using anti-vascular endothelial growth factor (anti-VEGF; aflibercept) slowed progression to severe ...

No, diabetes-related retinopathy is not reversible. But you can slow down progression or stop it from getting worse through diabetes management, eye injections, laser treatment, and more. Diabetic ...

Diabetic retinopathy involves damage to the eye’s retina due to high blood sugar levels in the body. It is a common complication of diabetes, affecting millions of people with both type 1 and type 2 ...